Free tool
Oncology stocks
We cover 3 companies grouped under the Oncology theme. The median market value in the group is $32.82B. Across the group, the median move over the past trading day is −1.14%. Price change over the past year runs from −12.5% to +45.4% across the middle 80 percent of the group, with a median of +9.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $71.92B | Large cap | +9.21% | Oct 27, 2026 |
| 4568.T | Daiichi Sankyo Company, Limited | $32.82B | Large cap | −17.94% | Oct 30, 2026 |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% | Oct 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.